Identify your healthiest
embryo

Mitigate your family's genetic predispositions with advanced genetic screening for your embryos

get access

How Orchid Works

1

Tell your doctor

Tell your doctor you'd like to screen your embryos with Orchid

2

Get your results

Receive advanced genetic reports for each embryo

3

Consult with experts

Board-certified genetic counselors walk you through your results

What you’ll learn

Protect your future child from genetic risks

Genetics influence the chance of developing disease later in life. Uncover risks and make an informed choice.

Orchid's advanced embryo screening measures:

Brain Health
  • Schizophrenia

  • Alzheimer’s Disease

Heart Health
  • Heart Disease

  • Atrial Fibrillation

  • Stroke

Cancers
  • Breast Cancer

  • Prostate Cancer

General Health
  • Inflammatory Bowel Disease

  • Type 1 & Type 2 Diabetes

the orchid difference

Orchid’s embryo test is the most advanced genetic risk assessment available for the top chronic conditions.

Analyze 100% of each embryo's genome

High quality results start with high quality, comprehensive data. We sequence the full genome of each embryo to provide the most advanced genetic risk assessment available.

 Screen for diseases that matter for every family

 

Genetics impacts every person’s health. We focus on measuring genetic susceptibility to chronic, debilitating diseases that affect over 60% of the population.

Expert-guided and trusted by leading fertility doctors

 

We’ve partnered with top reproductive medicine doctors and statistical geneticists to help validate our technology. We’re trusted by leading fertility clinics.

How it works

Insights to mitigate risks

1. Tell your doctor

Speak with your fertility doctor, who can order Orchid's embryo testing on your behalf.


Embryologists carefully prepare your samples and send them to our lab for analysis.

2.  Get your reports

We sequence your samples, and return a comprehensive report for each embryo.


Receive a prioritized list, from lowest genetic risk to highest, to inform your transfer plan.

3. Consult with experts

Board-certified genetic counselors are available to answer your questions.


Convenient online scheduling with evening and weekend availability.

take a peek

See a report

We’ll show you an example embryo report so you know exactly what you’ll learn.

Schedule demo
The Science

Simple results,
sophisticated science

Advances in computational and molecular biology allow us to measure genetic predisposition to disease more accurately than ever before. We analyze the entire genome to assess the specific genetic risks for each embryo.

Read more
our medical advisors

Orchid results are developed with world-class experts in reproductive medicine and genetics to give you the most accurate results.

Meet the scientists
Lusine Aghajanova, MD, PhD

Clinical Assistant Professor at the Stanford Medical Center

Ruben Alvero, MD

Professor of Obstetrics and Gynecology at the Stanford Medical Center

Jonathan Kort, MD

Reproductive Endocrinologist at RMA

Learn more from orchid guides

Keep Researching

Guide to embryo screening for chronic conditions

What to expect from embryo genetic risk screening

How your genetics impacts your future child's health

See all orchid guides
FAq

Our most common questions, answered.

How does your test help us prioritize embryos for implantation?

Screening your embryos created through IVF allows you to quantify each embryo’s genetic risk for breast cancer, prostate cancer, heart disease, atrial fibrillation, stroke, type 2 diabetes, type 1 diabetes, inflammatory bowel disease, schizophrenia and Alzheimer's. These results can help inform your transfer plan by prioritizing transferring embryos with the lowest genetic risk.

How does this test differ from other genetic testing on embryos? 


Orchid embryo test is the most advanced gentic risk assessment available for the top chronic conditions.
Our embryo report measures genetic predisposition for common conditions not included in other embryo genetic testing. PGT-A is included in Orchid’s test and is applicable to any couple, while PGT-M and PGT-SR are done only for specific clinical indications.

Currently, the different subtypes of preimplantation genetic testing (PGT) are referred to as:

  1. PGT-A (for aneuploidy) - screens for the number of chromosomes present to increase the chance of a successful pregnancy. Orchid’s embryo test includes PGT-A.

  2. PGT-M (for monogenic conditions) - used only for individuals or couples with a known risk of passing down a single gene disorder such as cystic fibrosis or Huntington’s disease.

  3. PGT-SR (for structural rearrangements) - used only for individuals with a chromosome rearrangement like a translocation or inversion.

What is the science behind Orchid?

For the first time ever, couples can safely and naturally reduce their future children’s genetic risk for the top 10 most common diseases.

For each embryo, Orchid sequences over 3 billion data points across the genome from the three to five cells carefully sampled and sent to our lab. Since each embryo has different DNA, each embryo has different genetic risks for chronic, common diseases. 

This is done by comparing the genetic makeup of hundreds of thousands of individuals diagnosed with the conditions we screen for (“cases”) with individuals without diseases (“controls”). Results from the embryo report can help inform your transfer plan to mitigate health risks for your future family. 

Learn more with a deeper dive into our science.

How is my privacy protected and my genetic data kept safe?

Your privacy is our top priority. We handle sensitive, personal information, and biological samples and we don’t take that lightly.

We guarantee that:

  • We do not sell your data to any third party, ever.

  • You can ask us to delete your data at any time, but this will mean that you cannot access the Orchid service to view your reports anymore.